Ohcanbohtosat - Thomas C. Marbury

Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment Dahkki Rajinder Bhardwaj, Mary K. Donohue, Jennifer Madonia, Beth Morris, Thomas C. Marbury, Kyle T. Matschke, Robert Croop, Richard Bertz, Jing Liu

Connect to this object online.

Phase 1 pharmacokinetic and safety study of soticlestat in participants with mild or moderate hepatic impairment or normal hepatic function Dahkki Wei Yin, Pranab Mitra, Veronique Copalu, Thomas C. Marbury, Juan Carlos Rondon, Eric J. Lawitz, Valerie Lloyd, Mike Baratta, Mahnaz Asgharnejad, Tom Hui, Yasir Khan

Connect to this object online.